1. Home
  2. TRX vs KPTI Comparison

TRX vs KPTI Comparison

Compare TRX & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TRX Gold Corporation

TRX

TRX Gold Corporation

N/A

Current Price

$1.15

Market Cap

383.1M

Sector

N/A

ML Signal

N/A

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$1.81

Market Cap

47.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRX
KPTI
Founded
1990
2008
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
383.1M
47.6M
IPO Year
2002
2013

Fundamental Metrics

Financial Performance
Metric
TRX
KPTI
Price
$1.15
$1.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$1.70
$16.00
AVG Volume (30 Days)
3.2M
1.2M
Earning Date
04-15-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$146,067,000.00
Revenue This Year
$84.84
N/A
Revenue Next Year
$96.90
$22.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.57
52 Week Low
$0.51
$1.72
52 Week High
$2.80
$10.99

Technical Indicators

Market Signals
Indicator
TRX
KPTI
Relative Strength Index (RSI) 61.50 26.02
Support Level $1.04 N/A
Resistance Level $1.34 $2.18
Average True Range (ATR) 0.06 0.16
MACD -0.01 0.23
Stochastic Oscillator 68.14 5.95

Price Performance

Historical Comparison
TRX
KPTI

About TRX TRX Gold Corporation

TRX Gold Corp is a high-margin and growing gold company advancing the Buckreef Gold Project in Tanzania. Buckreef Gold includes an established open-pit operation and approximately 2,000 tonnes per day process plant with upside potential demonstrated. The group is focused on creating both near-term and long-term shareholder value by increasing gold production to generate positive cash flow to fund the expansion as outlined in the PEA and grow Mineral Resources through exploration. TRX Gold's actions are led by the highest environmental, social, and corporate governance (ESG) standards, evidenced by the relationships and programs that the Company has developed during its nearly two decades of presence in the Geita Region, Tanzania.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: